Investment Analysts’ new coverage for Thursday, June 1st: Wedbush began coverage on shares of Arbor Realty Trust (NYSE:ABR). Wedbush issued an outperform rating on the stock. Stifel Nicolaus began coverage on shares of Ascent Industries (NASDAQ:ACNT). Stifel Nicolaus issued a buy rating on the stock. Oppenheimer Holdings Inc. started coverage on shares of Acrivon Therapeutics […]
Acrivon Therapeutics’ (NASDAQ:ACRV – Get Rating) lock-up period will expire on Monday, May 15th. Acrivon Therapeutics had issued 7,550,000 shares in its IPO on November 15th. The total size of the offering was $94,375,000 based on an initial share price of $12.50. Shares of the company owned by major shareholders and company insiders will be […]
Acrivon Therapeutics’ (NASDAQ:ACRV – Get Rating) lock-up period will end on Monday, May 15th. Acrivon Therapeutics had issued 7,550,000 shares in its initial public offering on November 15th. The total size of the offering was $94,375,000 based on an initial share price of $12.50. After the expiration of Acrivon Therapeutics’ lock-up period, restrictions preventing company […]
BMO Capital Markets started coverage on shares of Acrivon Therapeutics (NASDAQ:ACRV – Get Rating) in a research note published on Monday, The Fly reports. The firm issued an outperform rating and a $25.00 target price on the stock. Other analysts also recently issued research reports about the stock. LADENBURG THALM/SH SH started coverage on shares […]
Acrivon Therapeutics, Inc. (NASDAQ:ACRV – Get Rating) – HC Wainwright decreased their Q2 2023 earnings estimates for shares of Acrivon Therapeutics in a report issued on Wednesday, May 10th. HC Wainwright analyst E. Bodnar now expects that the company will post earnings per share of ($0.56) for the quarter, down from their previous estimate of […]
Acrivon Therapeutics Reports First Quarter 2023 Financial Results and Business Highlights streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Form 8-K Acrivon Therapeutics, For: May 09 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
LADENBURG THALM/SH SH initiated coverage on shares of Acrivon Therapeutics (NASDAQ:ACRV – Get Rating) in a report released on Thursday morning, The Fly reports. The firm issued a buy rating and a $22.00 target price on the stock. Separately, HC Wainwright assumed coverage on shares of Acrivon Therapeutics in a report on Thursday, April 20th. […]
Research Analysts’ new coverage for Thursday, April 27th: StockNews.com initiated coverage on shares of Atlas Air Worldwide (NASDAQ:AAWW). They issued a hold rating on the stock. LADENBURG THALM/SH SH began coverage on shares of Acrivon Therapeutics (NASDAQ:ACRV). They issued a buy rating and a $22.00 price target on the stock. StockNews.com started coverage on shares […]